000 01367 a2200373 4500
005 20250514051201.0
264 0 _c20030103
008 200301s 0 0 eng d
022 _a0028-3835
024 7 _a10.1159/000065951
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLandry, Michelle
245 0 0 _aEstrogenic properties of raloxifene, but not tamoxifen, on D2 and D3 dopamine receptors in the rat forebrain.
_h[electronic resource]
260 _bNeuroendocrinology
_cOct 2002
300 _a214-22 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aEstrogen Antagonists
_xpharmacology
650 0 4 _aFemale
650 0 4 _aOrgan Size
_xdrug effects
650 0 4 _aProsencephalon
_xmetabolism
650 0 4 _aRaloxifene Hydrochloride
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aReceptors, Dopamine D2
_xdrug effects
650 0 4 _aReceptors, Dopamine D3
650 0 4 _aSelective Estrogen Receptor Modulators
_xpharmacology
650 0 4 _aTamoxifen
_xpharmacology
650 0 4 _aUterus
_xanatomy & histology
700 1 _aLévesque, Daniel
700 1 _aDi Paolo, Thérèse
773 0 _tNeuroendocrinology
_gvol. 76
_gno. 4
_gp. 214-22
856 4 0 _uhttps://doi.org/10.1159/000065951
_zAvailable from publisher's website
999 _c12219801
_d12219801